Metraipolis › archive › dc_a04718ee3a28

Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease — Europe PMC PMID:42475369

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42475369
DOI
10.1371/journal.pone.0337880
License (as archived)
solo-consultazione
Archived
2026-10-18T04:02:19.415Z
SHA-256 of the archived text
5739ed62bc3c5e0c7824b07bcbcb524f7ec06e0eee39d2f377514b1cec0d6b9f
Stable URL of this page
https://metraipolis.com/documento/dc_a04718ee3a28

How to cite

Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease — Europe PMC PMID:42475369 — Europe PMC (en), https://europepmc.org/article/MED/42475369 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a04718ee3a28 (Metraipolis archive dc_a04718ee3a28, sha256 5739ed62bc3c5e0c7824b07bcbcb524f7ec06e0eee39d2f377514b1cec0d6b9f)
BibTeX
@misc{dca04718ee3a28,
  title = {Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease — Europe PMC PMID:42475369},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42475369},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a04718ee3a28; sha256 5739ed62bc3c5e0c7824b07bcbcb524f7ec06e0eee39d2f377514b1cec0d6b9f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42475369. Agents can read the archived copy with the MCP tool read_document.